I completely agree you have to include cost of failed candidates and did not mean to suggest I did not I mentioned the cash costs for developing an approved dr

I completely agree you have to include cost of failed candidates and did not mean to suggest I did not I mentioned the cash costs for developing an approved drug as an additional data point to that illustrate GPs $35M is too low even excluding cost of failure